Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma (Q40275475)
Jump to navigation
Jump to search
scientific article published on 25 May 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma |
scientific article published on 25 May 2006 |
Statements
1 reference
Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma (English)
1 reference
Christopher A Carter
1 reference
Charles Chen
1 reference
Cheryl Brink
1 reference
Patrick Vincent
1 reference
Yulia Y Maxuitenko
1 reference
Karen S Gilbert
1 reference
William R Waud
1 reference
Xiaomei Zhang
1 reference
25 May 2006
1 reference
1 reference
59
1 reference
2
1 reference
183-195
1 reference
Identifiers
1 reference
1 reference